Science Corporation Hits $3.5B Valuation on the Back of a Retinal Implant
A medical technology start-up founded by a former Neuralink executive just secured a massive valuation boost without relying on futuristic brain-computer interfaces quite yet.

A medical technology start-up founded by a former Neuralink executive just secured a massive valuation boost without relying on futuristic brain-computer interfaces quite yet. Science Corporation raised a $400 million Series D round that values the company at $3.5 billion, according to a person familiar with the deal. Backers including Khosla Ventures and Tenet Healthcare funded this jump, which pushes the five-year-old firm into deep-pocketed territory.
That money backs PRIMA, a wearable and implantable chip built to help patients with age-related macular degeneration recover some sight. The device works by bypassing damaged photoreceptors in the eye to stimulate underlying retinal cells directly. It is already approved in Europe and available in Germany, but the company now aims to clear regulatory hurdles in the United States using a pathway reserved for rare conditions.
To qualify, Science convinced federal regulators that advanced bilateral macular degeneration affects a small enough population to warrant an exemption meant for humanitarian devices. Our read suggests that leaning into a targeted ophthalmic device offers a faster commercial reality than invasive neural wiring. Yet founder Max Hodak has not abandoned the broader neural interface ambition that inspired the company in 2021.
Science is currently designing initial human trials with a Yale neurosurgery professor to test bio-hybrid sensors built from cultured neurons and silicon.
Those future trials aim to treat Parkinson's disease and other brain injuries, though those complex implants remain experimental.
Watch whether the company can successfully navigate US regulators to bring its vision-restoring chip to domestic patients.
The real test is whether a retinal implant can fund the much heavier lift of direct brain-machine interfaces.
The story so far
Earlier coverage connected by shared names and topics. Follow the dates to see how coverage developed; these links do not imply every article describes the same event.
Back to the Moon: Carnegie Hall’s Live Tribute to Apollo 11 Hits PBS on Nov. 10When the Apollo 11 launch lit up the sky, the world watched a 239,000‑mile journey unfold. Fifty years later, that same drama…
Connected by: HitsEARLIER COVERAGE
LangChain Doubles Valuation to $3B on the Back of Enterprise AI AgentsSoftware startups building autonomous digital workers are commanding massive valuations, and LangChain is leading the pack. The agent management company announced a…
Connected by: ValuationEARLIER COVERAGE
Corma Hits $1 Billion Valuation Three Months After LaunchAn AI cybersecurity startup called Corma reached a $1 billion valuation only three months after introducing its product, according to the company.…
Connected by: Khosla VenturesEARLIER COVERAGE
Genesis AI Raises $500M to Build Robots That Learn by HandWhen a $500 million robot fumbled a tiny box, it exposed the Achilles’ heel of physical AI. CEO Zhou Xian showed off…
Connected by: Khosla VenturesEARLIER COVERAGE- NOWScience Corporation Hits $3.5B Valuation on the Back of a Retinal ImplantCURRENT UPDATE
Original publication: 17 November 2026 19:56






